Biological standardization of allergenic extracts

Area of Science:

• Immunology
• Allergy Diagnostics
• Pharmacology

Background:

• Standardized allergenic extracts are vital for accurate allergy diagnosis and immunotherapy.
• Current skin testing methods vary in sensitivity, precision, and clinical utility.
• Evaluating the risk-benefit profile of immunotherapy relies on precise diagnostic tools.

Purpose of the Study:

• To compare the differentiating characteristics of parallel line bioassay and the ID50EAL method.
• To advocate for the preferential selection of sensitive and precise skin test methodologies.
• To emphasize the importance of proficiency testing in skin test methodologies for clinicians.

Main Methods:

• Comparison of parallel line bioassay and ID50EAL (intradermal dilution 50% erythema dose) methods.
• Focus on intradermal erythema response for bioassay standardization.
• Discussion of proficiency testing for puncture and intradermal skin tests.

Main Results:

• Parallel line bioassay and ID50EAL provide the most sensitive, accurate, and precise bioassays.
• These methods require fewer injections and replicates compared to others.
• Proficiency testing should be integrated into clinical practice and training.

Conclusions:

• Preferential clinical use of parallel line bioassay and ID50EAL is recommended for skin testing.
• Standardized allergenic extracts require accurate "in vivo" standardization methods.
• Assignment of Allergy Units based on "in vivo" and predictive "in vitro" assays ensures safe and effective immunotherapy.